Data / Drug companies / Prochlorperazine maleate
Prochlorperazine maleate: 31 companies and 62 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Prochlorperazine maleate is listed in the FDA National Drug Code Directory by 31 companies, with 62 products in commercial distribution. 62 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, film coated, and the newest product started marketing on August 19, 2026.
The request: Get every company that lists prochlorperazine maleate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 31
- Products
- 62
- Generic (ANDA) products
- 62 (100.0%)
- Application numbers
- 10
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list prochlorperazine maleate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Remedyrepack Inc. | 5 | tablet; tablet, film coated | Generic drugs (ANDA) | August 19, 2026 |
| Bionpharma Inc. | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | January 31, 2025 |
| Redpharm Drug | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | January 31, 2025 |
| A-S Medication Solutions | 3 | tablet; tablet, film coated | Generic drugs (ANDA) | January 31, 2025 |
| Bryant Ranch Prepack | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | September 13, 2023 |
| Ajanta Pharma USA Inc. | 2 | tablet | Generic drugs (ANDA) | May 9, 2024 |
| American Health Packaging | 2 | tablet, film coated | Generic drugs (ANDA) | October 14, 2024 |
| Amneal Pharmaceuticals NY LLC | 2 | tablet, film coated | Generic drugs (ANDA) | April 21, 2023 |
| Ani Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | August 1, 2022 |
| Aurobindo Pharma Limited | 2 | tablet, film coated | Generic drugs (ANDA) | September 8, 2025 |
| AvPAK | 2 | tablet | Generic drugs (ANDA) | April 16, 2019 |
| Chartwell RX, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | July 19, 1996 |
| Glenmark Pharmaceuticals Inc., USA | 2 | tablet | Generic drugs (ANDA) | May 28, 2025 |
| Jubilant Cadista Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | March 1, 1998 |
| Leading Pharma, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | June 25, 2025 |
| Major Pharmaceuticals | 2 | tablet, film coated | Generic drugs (ANDA) | August 1, 2022 |
| Northwind Health Company, LLC | 2 | tablet | Generic drugs (ANDA) | August 26, 2022 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | July 28, 2025 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | March 1, 1998 |
| Sportpharm LLC | 2 | tablet | Generic drugs (ANDA) | March 1, 1998 |
| Zydus Lifesciences Limited | 2 | tablet | Generic drugs (ANDA) | August 10, 2022 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet | Generic drugs (ANDA) | August 10, 2022 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | March 1, 1998 |
| Cardinal Health 107, LLC | 1 | tablet | Generic drugs (ANDA) | April 16, 2019 |
| Direct_Rx | 1 | tablet | Generic drugs (ANDA) | August 3, 2023 |
| NorthStar RxLLC | 1 | tablet | Generic drugs (ANDA) | September 7, 2023 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | February 6, 2024 |
| NuCare Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | March 1, 1998 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | March 1, 1998 |
| Preferred Pharmaceuticals Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | July 1, 2024 |
| QPharma, Inc. | 1 | tablet | Generic drugs (ANDA) | March 1, 1998 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 38 | 61.3% |
| Tablet, film coated | 24 | 38.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 62 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Phenothiazine | 62 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.